Syncom Formulations (India) standalone net profit declines 1.33% in the March 2017 quarter

Sales rise 2.01% to Rs 48.26 crore

Net profit of Syncom Formulations (India) declined 1.33% to Rs 2.22 crore in the quarter ended March 2017 as against Rs 2.25 crore during the previous quarter ended March 2016. Sales rose 2.01% to Rs 48.26 crore in the quarter ended March 2017 as against Rs 47.31 crore during the previous quarter ended March 2016.

For the full year,net profit rose 1.64% to Rs 10.53 crore in the year ended March 2017 as against Rs 10.36 crore during the previous year ended March 2016. Sales rose 0.47% to Rs 182.75 crore in the year ended March 2017 as against Rs 181.90 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales48.2647.31 2 182.75181.90 0 OPM %5.885.69 -7.898.04 - PBDT3.744.24 -12 19.0019.21 -1 PBT3.123.79 -18 15.8816.21 -2 NP2.222.25 -1 10.5310.36 2

Powered by Capital Market - Live News